Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 4
1983 5
1984 7
1985 2
1986 1
1987 8
1988 8
1989 5
1990 3
1991 6
1992 4
1993 5
1994 4
1995 5
1996 7
1997 3
1998 6
1999 7
2000 1
2001 5
2002 3
2003 9
2004 6
2005 4
2006 10
2007 4
2008 9
2009 14
2010 10
2011 11
2012 19
2013 5
2014 6
2015 13
2016 14
2017 21
2018 25
2019 19
2020 19
2021 17
2022 20
2023 17
2024 30
2025 14
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

377 results

Results by year

Filters applied: . Clear all
Page 1
The monoclonals: What have we learned and where are we going?
Pepper AN, Casale TB. Pepper AN, et al. Among authors: casale tb. Ann Allergy Asthma Immunol. 2026 May 10:S1081-1206(26)00206-1. doi: 10.1016/j.anai.2026.05.006. Online ahead of print. Ann Allergy Asthma Immunol. 2026. PMID: 42119664 Review.
No evidence of a differential treatment effect with omalizumab versus placebo across baseline IgE level and BMI subgroups in patients with chronic spontaneous urticaria.
Mosnaim G, Bernstein JA, Holden M, Trzaskoma BL, Casale TB. Mosnaim G, et al. Among authors: casale tb. J Allergy Clin Immunol Pract. 2026 Apr 28:S2213-2198(26)00337-5. doi: 10.1016/j.jaip.2026.04.015. Online ahead of print. J Allergy Clin Immunol Pract. 2026. PMID: 42061708 Free article. No abstract available.
Efficacy of Epinephrine Nasal Spray in the Treatment of Urticaria.
Bernstein DI, Talreja N, Casale TB, Li HH, Kaliner MA, Lowenthal R, Tanimoto S. Bernstein DI, et al. Among authors: casale tb. J Allergy Clin Immunol Pract. 2026 May;14(5):1184-1189. doi: 10.1016/j.jaip.2026.02.010. Epub 2026 Feb 17. J Allergy Clin Immunol Pract. 2026. PMID: 41702470 Free article. Clinical Trial.
Pharmacokinetics and Pharmacodynamics Following Repeat Dosing of neffy (Epinephrine Nasal Spray) Versus Intramuscular Injection During Induced Allergic Rhinitis.
Oppenheimer J, Casale TB, Spergel JM, Bernstein DI, Camargo CA Jr, Ellis AK, Fleischer DM, Lowenthal R, Tanimoto S. Oppenheimer J, et al. Among authors: casale tb. J Allergy Clin Immunol Pract. 2026 Apr;14(4):837-845.e3. doi: 10.1016/j.jaip.2026.02.005. Epub 2026 Feb 11. J Allergy Clin Immunol Pract. 2026. PMID: 41687867 Free article. Clinical Trial.
Non-injectable versus injectable epinephrine treatment thresholds for acute allergic reactions in the community.
Dribin TE, Sampson HA, Schnadower D, Anagnostou A, Fox AT, Golden DBK, Michelson KA, Shaker MS, Wang J, Alqurashi W, Assa'ad AH, Brousseau DC, Campbell DE, Campbell RL, Casale TB, Chu DK, Devonshire AL, Ebisawa M, Greenhawt M, Lang DM, Liebermann JA, Leonard S, Mack DP, Muraro A, Neuman MI, Risma KA, Roberts G, Sargant N, Sicherer SH, Spergel JM, Wallace D, Waserman S, Worm M, Kahmann V, Sobolewski B, Zhang Y, Boyd S, Zhang N, Eftekhari S, Jaffee H, Carver M, Camargo CA Jr. Dribin TE, et al. Among authors: casale tb. J Allergy Clin Immunol Pract. 2026 Apr;14(4):976-980. doi: 10.1016/j.jaip.2025.12.022. Epub 2025 Dec 30. J Allergy Clin Immunol Pract. 2026. PMID: 41478402 No abstract available.
Epinephrine and emergency medical services activation recommendations during acute allergic reactions in community settings: International consensus report.
Dribin TE, Sampson HA, Anagnostou A, Camargo CA Jr, Fox AT, Golden DBK, Michelson KA, Shaker MS, Wang J, Alqurashi W, Assa'ad AH, Brousseau DC, Campbell DE, Campbell RL, Casale TB, Chu DK, Devonshire AL, Ebisawa M, Greenhawt M, Lang DM, Liebermann JA, Leonard S, Mack DP, Muraro A, Neuman MI, Risma KA, Roberts G, Sargant N, Sicherer SH, Spergel JM, Wallace D, Waserman S, Worm M, Bush HR, Giambra BK, Vaughn LM, Kahmann V, Sobolewski B, Zhang Y, Boyd S, Eftekhari S, Jaffee H, Carver M, Keefer R, Douglas L, Nickels C, Moore RA, Schnadower D. Dribin TE, et al. Among authors: casale tb. J Allergy Clin Immunol. 2026 Feb;157(2):429-441. doi: 10.1016/j.jaci.2025.11.008. Epub 2025 Dec 10. J Allergy Clin Immunol. 2026. PMID: 41386477
Dupilumab Improves Health-Related Quality of Life in Omalizumab-Naïve Patients with Chronic Spontaneous Urticaria.
Giménez-Arnau AM, Casale TB, Yosipovitch G, Ensina LF, Inomata N, Msihid J, Makhija M, Radin A, Cyr SL, Sugerman P, Thomas RB, Chuang CC. Giménez-Arnau AM, et al. Among authors: casale tb. Dermatol Ther (Heidelb). 2026 Jan;16(1):549-562. doi: 10.1007/s13555-025-01605-w. Epub 2025 Dec 2. Dermatol Ther (Heidelb). 2026. PMID: 41326897 Free PMC article.
377 results